Literature DB >> 30614030

Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.

Danielle Aparecida Guimaraes1, Jose Eduardo Tanus-Santos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30614030      PMCID： PMC6475684          DOI： 10.1111/bcp.13835

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

Review 1.  The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.

Authors:  Jon O Lundberg; Eddie Weitzberg; Mark T Gladwin
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension.

Authors:  Lucas C Pinheiro; Jefferson H Amaral; Graziele C Ferreira; Rafael L Portella; Carla S Ceron; Marcelo F Montenegro; Jose Carlos Toledo; Jose E Tanus-Santos
Journal:  Free Radic Biol Med       Date:  2015-07-06       Impact factor: 7.376

3.  A high fat diet induces sex-specific differences in hepatic lipid metabolism and nitrite/nitrate in rats.

Authors:  Julijana Stanimirovic; Milan Obradovic; Aleksandra Jovanovic; Emina Sudar-Milovanovic; Sonja Zafirovic; Samantha J Pitt; Alan J Stewart; Esma R Isenovic
Journal:  Nitric Oxide       Date:  2016-02-26       Impact factor: 4.427

4.  Nitrite exerts antioxidant effects, inhibits the mTOR pathway and reverses hypertension-induced cardiac hypertrophy.

Authors:  Danielle A Guimaraes; Madla A Dos Passos; Elen Rizzi; Lucas C Pinheiro; Jefferson H Amaral; Raquel F Gerlach; Michele M Castro; Jose E Tanus-Santos
Journal:  Free Radic Biol Med       Date:  2018-03-09       Impact factor: 7.376

5.  Dietary nitrite attenuates oxidative stress and activates antioxidant genes in rat heart during hypobaric hypoxia.

Authors:  Manjulata Singh; Aditya Arya; Rajesh Kumar; Kalpana Bhargava; Niroj Kumar Sethy
Journal:  Nitric Oxide       Date:  2011-12-14       Impact factor: 4.427

6.  Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice.

Authors:  Wei Chih Ling; Mohd Rais Mustafa; Paul M Vanhoutte; Dharmani Devi Murugan
Journal:  Vascul Pharmacol       Date:  2017-05-26       Impact factor: 5.773

7.  The antihypertensive effects of sodium nitrite are not associated with circulating angiotensin converting enzyme inhibition.

Authors:  Lucas C Pinheiro; Jefferson H Amaral; Graziele C Ferreira; Marcelo F Montenegro; Gustavo H Oliveira-Paula; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2014-05-27       Impact factor: 4.427

8.  Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trial.

Authors:  Luca Faconti; Charlotte Elizabeth Mills; Virginia Govoni; Haotian Gu; Steven Morant; Benju Jiang; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2018-11-13       Impact factor: 4.335

Review 9.  Nitric oxide in hypertension.

Authors:  Matthias Hermann; Andreas Flammer; Thomas F Lüscher
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 10.  Diabetes and hypertension: is there a common metabolic pathway?

Authors:  Bernard M Y Cheung; Chao Li
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113
View more
  2 in total

1.  Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.

Authors:  Danielle Aparecida Guimaraes; Jose Eduardo Tanus-Santos
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

2.  Reply to 'Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.'

Authors:  Luca Faconti; J Kennedy Cruickshank; Andrew James Webb
Journal:  Br J Clin Pharmacol       Date:  2019-03-04       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.